| Literature DB >> 26788168 |
Guo Li1, Chao Liu1, Yong Liu1, Fang Xu1, Zhongwu Su1, Yunyun Wang1, Shuling Ren1, Tengbo Deng1, Donghai Huang1, Yongquan Tian1, Yuanzheng Qiu1.
Abstract
Malignant triton tumor (MTT) is a malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation. The prognosis of patients is poor, and due to its rarity, large case studies are lacking. The aim of this study is to describe the clinical features and identify potential prognostic factors. Two patients with MTT in the head and neck treated at our department are reported. A literature search revealed another 198 published cases. All of these cases then went through a retrospective analysis. The ratio of male-to-female incidence was 1.5:1, and the median age at diagnosis was 29 years. In 41.7% of cases it occurred in patients with neurofibromatosis type 1. The five-year survival of MTT was found to be just 35%. Cox proportional hazards analysis revealed that complete resection (hazard ratio, 0.396; P=0.032) and metastases (hazard ratio, 3.188; P=0.004) were associated with mortality, indicating that complete resection may lead to a longer life span, and that the existence of metastasis suggested a worse prognosis for patients with MTT.Entities:
Keywords: malignant triton tumor; prognosis; surgery; survival analyses
Year: 2015 PMID: 26788168 PMCID: PMC4665219 DOI: 10.3892/ol.2015.3762
Source DB: PubMed Journal: Oncol Lett ISSN: 1792-1074 Impact factor: 2.967